ITIH3 and myasthenia gravis: We identified inter-alpha-trypsin inhibitor heavy chain H3 (ITIH3) as a potential biomarker for disease activity in MG using a machine learning (ML) algorithm.[3, 7, 8, 14, 26, 38] As previously reported, anti-AChR-Ab levels did not correlate with clinical outcomes in our cohort.